PepTcell

CompanyUnited KingdomFounded 2003

Wikidata

PepTcell develops one asset, in phase 3 (FLU-v in influenza). Mostly vaccine acting on inflammation; based in the United Kingdom, founded in 2003.

1
Asset
Furthest stage
Phase 3
2
Trials
0
Signals

Pipeline

1
  • FLU-v

    Inactivated influenza virus vaccine inducing protective antibody responses

    Phase 3, Vaccine, Inflammation, influenza, influenza immunization

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials2
  • Similar companies6

Intelligence